Iron Reshapes the Gut Microbiome and Host Metabolism

키워드

참고문헌 (212)

1. Jia W, "Gut microbiota : a potential new territory for drug targeting", Nat Rev Drug Discov, 7, pp.123~129 (2008)
2. Gomes AC, "Gut microbiota, probiotics and diabetes", Nutr J, 13, pp.60~ (2014)
3. Sender R, "Revised estimates for the number of human and bacteria cells in the body", PLoS Biol, 14, pp.e1002533~ (2016)
4. Wu GD, "Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags", BMC Microbiol, 10, pp.206~ (2010)
5. Eckburg PB, "Diversity of the human intestinal microbial flora", Science, 308, pp.1635~1638 (2005)
6. Flint HJ, "Interactions and competition within the microbial community of the human colon : links between diet and health", Environ Microbiol, 9, pp.1101~1111 (2007)
7. Imbert M, "On the iron requirement of lactobacilli grown in chemically defined medium", Curr Microbiol, 37, pp.64~66 (1998)
8. Weinberg ED, "The Lactobacillus anomaly : total iron abstinence", Perspect Biol Med, 40, pp.578~583 (1997)
9. Wu ZA, "A systematic review of the interaction between gut microbiota and host health from a symbiotic perspective", SN Compr Clin Med, 1, pp.224~235 (2019)
10. Martens EC, "The devil lies in the details : How variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes", J Mol Biol, 426, pp.3851~3865 (2014)
11. Derrien M, "Rethinking diet to aid human-microbe symbiosis", Trends Microbiol, 25, pp.100~112 (2017)
12. Petersen C, "Defining dysbiosis and its influence on host immunity and disease", Cell Microbiol, 16, pp.1024~1033 (2014)
13. Nishida A, "Gut microbiota in the pathogenesis of inflammatory bowel disease", Clin J Gastroenterol, 11, pp.1~10 (2018)
14. Scher JU, "The microbiome and rheumatoid arthritis", Nat Rev Rheumatol, 7, pp.569~578 (2011)
15. Sun MF, "Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease", Ageing Res Rev, 45, pp.53~61 (2018)
16. Hao ML, "Gut microbiota : an overlooked factor that plays a significant role in osteoporosis", J Int Med Res, 47, pp.4095~4103 (2019)
17. Honda K, "The microbiome in infectious disease and inflammation", Annu Rev Immunol, 30, pp.759~795 (2012)
18. Chen X, "Gut microbiome in obesity, metabolic syndrome, and diabetes", Curr Diab Rep, 18, pp.129~ (2018)
19. Baothman OA, "The role of gut microbiota in the development of obesity and diabetes", Lipids Health Dis, 15, pp.108~ (2016)
20. Ferreira RB, "The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization", PLoS One, 6, pp.e20338~ (2011)
21. Sprinz H, "The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri", Am J Pathol, 39, pp.681~695 (1961)
22. Zachar Z, "Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes", Infect Immun, 23, pp.168~174 (1979)
23. Kamada N, "Regulated virulence controls the ability of a pathogen to compete with the gut microbiota", Science, 336, pp.1325~1329 (2012)
24. Quince C, "Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition", Am J Gastroenterol, 110, pp.1718~1729 (2015)
25. Andoh A, "Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease", J Gastroenterol, 47, pp.1298~1307 (2012)
26. Liang D, "Involvement of gut microbiome in human health and disease : brief overview, knowledge gaps and research opportunities", Gut Pathog, 10, pp.3~ (2018)
27. Mohajeri MH, "The role of the microbiome for human health : from basic science to clinical applications", Eur J Nutr, 57, pp.1~14 (2018)
28. Brooks AW, "Gut microbiota diversity across ethnicities in the United States", PLoS Biol, 16, pp.e2006842~ (2018)
29. Tasnim N, "Linking the gut microbial ecosystem with the environment : Does gut health depend on where we live?", Front Microbiol, 8, pp.1935~ (2017)
30. Deschasaux M, "Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography", Nat Med, 24, pp.1526~1531 (2018)
31. He Y, "Regional variation limits applications of healthy gut microbiome reference ranges and disease models", Nat Med, 24, pp.1532~1535 (2018)
32. Galkin F, "Human gut microbiome aging clock based on taxonomic profiling and deep learning", iScience, 23, pp.101199~ (2020)
33. Haro C, "Intestinal microbiota is influenced by gender and body mass index", PLoS One, 11, pp.e0154090~ (2016)
34. Kasai C, "Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing", BMC Gastroenterol, 15, pp.100~ (2015)
35. Suzuki Y, "Association between yogurt consumption and intestinal microbiota in healthy young adults differs by host gender", Front Microbiol, 8, pp.847~ (2017)
36. Vatanen T, "The human gut microbiome in early-onset type 1 diabetes from the TEDDY study", Nature, 562, pp.589~594 (2018)
37. Bokulich NA, "Antibiotics, birth mode, and diet shape microbiome maturation during early life", Sci Transl Med, 8, pp.343~ (2016)
38. Santos-Marcos JA, "Sex differences in the gut microbiota as potential determinants of gender predisposition to disease", Mol Nutr Food Res, 63, pp.e1800870~ (2019)
39. Levy G, "The human microbiome and gender medicine", Gend Genome, 2, pp.123~127 (2018)
40. Turnbaugh PJ, "A core gut microbiome in obese and lean twins", Nature, 457, pp.480~484 (2009)
41. Goodrich JK, "Human genetics shape the gut microbiome", Cell, 159, pp.789~799 (2014)
42. Dąbrowska K, "Correlations of host genetics and gut microbiome composition", Front Microbiol, 7, pp.1357~ (2016)
43. Gomez A, "Plasticity in the human gut microbiome defies evolutionary constraints", MSphere, 4, pp.e00271~19 (2019)
44. Singh RK, "Influence of diet on the gut microbiome and implications for human health", J Transl Med, 15, pp.73~ (2017)
45. Voreades N, "Diet and the development of the human intestinal microbiome", Front Microbiol, 5, pp.494~ (2014)
46. Rajoka MS, "Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health", Food Sci Hum Well, 6, pp.121~130 (2017)
47. Medeiros P, "The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host", Virulence, 4, pp.624~633 (2013)
48. Dostal A, "Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation : a randomised, placebo-controlled intervention trial in South African children", Br J Nutr, 112, pp.547~556 (2014)
49. Dostal A, "Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats", Br J Nutr, 111, pp.2135~2145 (2014)
50. Tan G, "Copper binding in IscA inhibits iron-sulphur cluster assembly in Escherichia coli", Mol Microbiol, 93, pp.629~644 (2014)
51. Lopez CA, "The impact of dietary transition metals on host-bacterial interactions", Cell Host Microbe, 23, pp.737~748 (2018)
52. Smits SA, "Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania", Science, 357, pp.802~806 (2017)
53. Gentile CL, "The gut microbiota at the intersection of diet and human health", Science, 362, pp.776~780 (2018)
54. Dahl WJ, "Diet, nutrients and the microbiome", Prog Mol Biol Transl Sci, 171, pp.237~263 (2020)
55. Craig WJ, "Nutrition concerns and health effects of vegetarian diets", Nutr Clin Pract, 25, pp.613~620 (2010)
56. Dinu M, "Vegetarian, vegan diets and multiple health outcomes : a systematic review with meta-analysis of observational studies", Crit Rev Food Sci Nutr, 57, pp.3640~3649 (2017)
57. Lee Y, "Adherence to a vegetarian diet and diabetes risk : a systematic review and meta-analysis of observational studies", Nutrients, 9, pp.603~ (2017)
58. Pilis W, "Health benefits and risk associated with adopting a vegetarian diet", Rocz Panstw Zakl Hig, 65, pp.9~14 (2014)
59. Trefflich I, "Is a vegan or a vegetarian diet associated with the microbiota composition in the gut? Results of a new cross-sectional study and systematic review", Crit Rev Food Sci Nutr, 60, pp.2990~3004 (2020)
60. Panda S, "Short-term effect of antibiotics on human gut microbiota", PLoS One, 9, pp.e95476~ (2014)
61. Dethlefsen L, "Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation", Proc Natl Acad Sci U S A 2011;108 Suppl, 108(Suppl 1), pp.4554~4561 (2011)
62. Imhann F, "The influence of proton pump inhibitors and other commonly used medication on the gut microbiota", Gut Microbes, 8, pp.351~358 (2017)
63. Lin IC, "Management of the ptotic or hypertrophic breast in immediate autologous breast reconstruction : a comparison between the wise and vertical reduction patterns for mastectomy", Ann Plast Surg, 70, pp.264~270 (2013)
64. Tomova A, "The effects of vegetarian and vegan diets on gut microbiota", Front Nutr, 6, pp.47~ (2019)
65. De Angelis M, "Diet influences the functions of the human intestinal microbiome", 10, pp.427~ (2020)
66. De Filippis F, "High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome", Gut, 65, pp.1812~1821 (2016)
67. Salas-Salvadó J, "Prevention of diabetes with Mediterranean diets : a subgroup analysis of a randomized trial", Ann Intern Med, 160, pp.1~10 (2014)
68. Widmer RJ, "The Mediterranean diet, its components, and cardiovascular disease", Am J Med, 128, pp.229~238 (2015)
69. Sofi F, "Accruing evidence on benefits of adherence to the Mediterranean diet on health : an updated systematic review and meta-analysis", Am J Clin Nutr, 92, pp.1189~1196 (2010)
70. Pastori D, "Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation : effect of adherence to Mediterranean diet", J Am Heart Assoc, 6, pp.e005784~ (2017)
71. Garcia-Mantrana I, "Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population", Front Microbiol, 9, pp.890~ (2018)
72. Meslier V, "Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake", Gut, 69, pp.1258~1268 (2020)
73. Zhou L, "Faecalibacterium prausnitzii produces butyrate to maintain Th17", Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1, 2018, pp.24, 1926~1940
74. Zinöcker MK, "The western diet-microbiome-host interaction and its role in metabolic disease", Nutrients, 10, pp.365~ (2018)
75. Hehemann JH, "Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota", Nature, 464, pp.908~912 (2010)
76. De Filippo C, "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proc Natl Acad Sci U S A, 107, pp.14691~14696 (2010)
77. Shikany JM, "Association of dietary patterns with the gut microbiota in older, community-dwelling men", Am J Clin Nutr, 110, pp.1003~1014 (2019)
78. Whisner CM, "Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing : a cross-sectional study", BMC Microbiol, 18, pp.210~ (2018)
79. Schnorr SL, "Gut microbiome of the Hadza hunter-gatherers", Nat Commun, 5, pp.3654~ (2014)
80. Clemente JC, "The microbiome of uncontacted Amerindians", Sci Adv, 1, pp.e1500183~ (2015)
81. Obregon-Tito AJ, "Subsistence strategies in traditional societies distinguish gut microbiomes", Nat Commun, 6, pp.6505~ (2015)
82. Martínez I, "The gut microbiota of rural papua new guineans : composition, diversity patterns, and ecological processes", Cell Reports, 11, pp.527~538 (2015)
83. Macfarlane GT, "Bacteria, colonic fermentation, and gastrointestinal health", J AOAC Int, 95, pp.50~60 (2012)
84. So D, "Dietary fiber intervention on gut microbiota composition in healthy adults : a systematic review and meta-analysis", Am J Clin Nutr, 107, pp.965~983 (2018)
85. Kamarul Zaman M, "Fiber and prebiotic supplementation in enteral nutrition : a systematic review and meta-analysis", World J Gastroenterol, 21, pp.5372~5381 (2015)
86. Martínez I, "Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects", PLoS One, 5, pp.e15046~ (2010)
87. Do MH, "High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change", Nutrients, 10, pp.761~ (2018)
88. Jang C, "The small intestine converts dietary fructose into glucose and organic acids", Cell Metab, 27, pp.351~361 (2018)
89. Coelho OG, "Dietary fat and gut microbiota : mechanisms involved in obesity control", Crit Rev Food Sci Nutr, 59, pp.3045~3053 (2019)
90. Menni C, "Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women", Sci Rep, 7, pp.11079~ (2017)
91. Caesar R, "Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling", Cell Metab, 22, pp.658~668 (2015)
92. Bäckhed F, "Mechanisms underlying the resistance to diet-induced obesity in germ-free mice", Proc Natl Acad Sci U S A, 104, pp.979~984 (2007)
93. Rabot S, "Germ-free C57BL", 6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism, 2010, pp.24, 4948~4959
94. Ding S, "High-fat diet : bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse", PLoS One, 5, pp.e12191~ (2010)
95. Bäckhed F, "The gut microbiota as an environmental factor that regulates fat storage", Proc Natl Acad Sci U S A, 101, pp.15718~15723 (2004)
96. Jandhyala SM, "Role of the normal gut microbiota", World J Gastroenterol, 21, pp.8787~8803 (2015)
97. Chakraborti CK, "New-found link between microbiota and obesity", World J Gastrointest Pathophysiol, 6, pp.110~119 (2015)
98. Rahat-Rozenbloom S, "Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans", Int J Obes, 38, pp.1525~1531 (2014)
99. Shortt C, "Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients", Eur J Nutr, 57, pp.25~49 (2018)
100. Jumpertz R, "Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans", Am J Clin Nutr, 94, pp.58~65 (2011)
101. Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
102. Stephens RW, "Gut microbiota: from microorganisms to metabolic organ influencing obesity", Obesity (Silver Spring), 26, pp.801~809 (2018)
103. Schwiertz A, "Microbiota and SCFA in lean and overweight healthy subjects", Obesity(Silver Spring), 18, pp.190~195 (2010)
104. Million M, "Gut bacterial microbiota and obesity", Clin Microbiol Infect, 19, pp.305~313 (2013)
105. Vrieze A, "Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome", Gastroenterology, 143, pp.913~916 (2012)
106. Barreto FM, "Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome", Nutrition, 30, pp.939~942 (2014)
107. Lee E, "Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid metabolism", Nutrients, 10, pp.643~ (2018)
108. Uchinaka A, "Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome", Sci Rep, 8, pp.8156~ (2018)
109. Lim MY, "The effect of heritability and host genetics on the gut microbiota and metabolic syndrome", Gut, 66, pp.1031~1038 (2017)
110. Peter Sommer, "Functional and Mechanistic Integration of Infection and the Metabolic Syndrome", Diabetes and Metabolism Journal, 34(2), pp.71~76 (2010), 대한당뇨병학회
111. Paganini D, "The effects of iron fortification and supplementation on the gut microbiome and diarrhea in infants and children : a review", Am J Clin Nutr, 106, pp.1688~ (2017)
112. Chieppa M, "Immune cells and microbiota response to iron starvation", Front Med(Lausanne), 5, pp.109~ (2018)
113. Yilmaz B, "Gut microbiota and iron: the crucial actors in health and disease", Pharmaceuticals(Basel), 11, pp.98~ (2018)
114. Rask-Madsen C, "Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease", Arterioscler Thromb Vasc Biol, 32, pp.2052~2059 (2012)
115. Ford ES, "Increasing prevalence of the metabolic syndrome among U. S. adults", Diabetes Care, 27, pp.2444~2449 (2004)
116. Sperling LS, "The CardioMetabolic Health Alliance : working toward a new care model for the metabolic syndrome", J Am Coll Cardiol, 66, pp.1050~1067 (2015)
117. Lee DH, "Common presence of non-transferrin-bound iron among patients with type 2 diabetes", Diabetes Care, 29, pp.1090~1095 (2006)
118. Aljwaid H, "Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes", J Diabetes Complications, 29, pp.943~949 (2015)
119. Bozzini C, "Prevalence of body iron excess in the metabolic syndrome", Diabetes Care, 28, pp.2061~2063 (2005)
120. Fernández-Real JM, "Serum ferritin as a component of the insulin resistance syndrome", Diabetes Care, 21, pp.62~68 (1998)
121. Mendler MH, "Insulin resistance-associated hepatic iron overload", Gastroenterology, 117, pp.1155~1163 (1999)
122. Deugnier Y, "Dysmetabolic iron overload syndrome(DIOS)", Presse Med, 46, pp.e306~ (2017)
123. Sachinidis A, "Dysmetabolic iron overload in metabolic syndrome", Curr Pharm Des, 26, pp.1019~1024 (2020)
124. Buret AG, "Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases : a role for iron?", J Biomed Sci, 26, pp.1~ (2019)
125. Ortiz-Flores AE, "Iron overload in functional hyperandrogenism: in a randomized trial, bloodletting does not improve metabolic outcomes", J Clin Endocrinol Metab (2021)
126. Behboudi-Gandevani S, "Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome : a randomized controlled trial", J Ovarian Res, 12, pp.78~ (2019)
127. Baye E, "Carnosine supplementation reduces plasma soluble transferrin receptor in healthy overweight or obese individuals : a pilot randomised trial", Amino Acids, 51, pp.73~81 (2019)
128. Suárez-Ortegón MF, "Ferritin, metabolic syndrome and its components : a systematic review and meta-analysis", Atherosclerosis, 275, pp.97~106 (2018)
129. Chuansumrit A, "Effect of iron chelation therapy on glucose metabolism in non-transfusion-dependent thalassaemia", Acta Haematol, 137, pp.20~26 (2017)
130. Lainé F, "Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome : a randomized controlled study in 274 patients", Hepatology, 65, pp.465~474 (2017)
131. Adams LA, "The impact of phlebotomy in nonalcoholic fatty liver disease : a prospective, randomized, controlled trial", Hepatology, 61, pp.1555~1564 (2015)
132. Valenti L, "A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia", World J Gastroenterol, 20, pp.3002~3010 (2014)
133. Beaton MD, "Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 37, pp.720~729 (2013)
134. Houschyar KS, "Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome : results from a randomized clinical trial", BMC Med, 10, pp.54~ (2012)
135. Schümann K, "Safety aspects of iron in food", Ann Nutr Metab, 45, pp.91~101 (2001)
136. Comerford KB, "Recent developments in multivitamin", mineral research, 2013, pp.4, 644~656
137. Stoffel NU, "Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women : two open-label, randomised controlled trials", Lancet Haematol, 4, pp.e524~e533 (2017)
138. Busserolles J, "Metabolic syndrome in the rat: females are protected against the pro-oxidant effect of a high sucrose diet", Exp Biol Med (Maywood), 227, pp.837~842 (2002)
139. Chan YK, "Iron metabolism and regulation by neutrophil gelatinase-associated lipocalin in cardiomyopathy", Clin Sci(Lond), 129, pp.851~862 (2015)
140. Sanchez KK, "Cooperative metabolic adaptations in the host can favor asymptomatic infection and select for attenuated virulence in an enteric pathogen", Cell, 175, pp.146~158 (2018)
141. Wongjaikam S, "Current and future treatment strategies for iron overload cardiomyopathy", Eur J Pharmacol, 765, pp.86~93 (2015)
142. Datz C, "Iron homeostasis in the metabolic syndrome", Eur J Clin Invest, 43, pp.215~224 (2013)
143. Rajpathak SN, "The role of iron in type 2 diabetes in humans", Biochim Biophys Acta, 1790, pp.671~681 (2009)
144. Murali AR, "Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease", Hepatol Res, 48, pp.E30~E41 (2018)
145. Aigner E, "Obesity as an emerging risk factor for iron deficiency", Nutrients, 6, pp.3587~3600 (2014)
146. Fernández-Real JM, "Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes", Diabetes Care, 38, pp.2169~2176 (2015)
147. Taher AT, "Thalassaemia", Lancet, 391, pp.155~167 (2018)
148. Abdulsada SH, "Metabolic syndrome in Iraqi female patients with major β-thalassemia", Al-Mustansiriyah J Sci, 27, pp.39~42 (2016)
149. Saki F, "Prevalence of metabolic syndrome in beta thalassemia major adolescents in southern Iran : a cross-sectional study", Int J Diabetes Dev Ctries, 39, pp.444~450 (2019)
150. Azami M, "Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran : a meta-analysis study", Caspian J Intern Med, 8, pp.1~15 (2017)
151. Li MJ, "Diabetes mellitus in patients with thalassemia major", Pediatr Blood Cancer, 61, pp.20~24 (2014)
152. Gamberini MR, "Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center", Pediatr Endocrinol Rev, 2(Suppl 2), pp.285~291 (2004)
153. Levi S, "The role of iron in mitochondrial function", Biochim Biophys Acta, 1790, pp.629~636 (2009)
154. Hesselink MK, "Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus", Nat Rev Endocrinol, 12, pp.633~645 (2016)
155. Visitchanakun P, "Gut leakage enhances sepsis susceptibility in iron-overloaded β-thalassemia mice through macrophage hyperinflammatory responses", Am J Physiol Gastrointest Liver Physiol, 318, pp.G966~ (2020)
156. Pantopoulos K, "Inherited disorders of iron overload", Front Nutr, 5, pp.103~ (2018)
157. Allen KJ, "Iron-overload-related disease in HFE hereditary hemochromatosis", N Engl J Med, 358, pp.221~230 (2008)
158. Utzschneider KM, "Hereditary hemochromatosis and diabetes mellitus : implications for clinical practice", Nat Rev Endocrinol, 6, pp.26~33 (2010)
159. Fillebeen C, "Regulatory connections between iron and glucose metabolism", Int J Mol Sci, 21, pp.7773~ (2020)
160. Sivaprakasam S, "Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice", Biochem J, 477, pp.3867~3883 (2020)
161. Gabrielsen JS, "Adipocyte iron regulates adiponectin and insulin sensitivity", J Clin Invest, 122, pp.3529~3540 (2012)
162. Symeonidis A, "Insight and control of Infectious disease in global scenario", pp.289~330 (2012), IntechOpen
163. Andrews SC, "Bacterial iron homeostasis", FEMS Microbiol Rev, 27, pp.215~237 (2003)
164. Golonka R, "The iron tug-of-war between bacterial siderophores and innate immunity", J Innate Immun, 11, pp.249~262 (2019)
165. Rocha ER, "Effect of ferric and ferrous iron chelators on growth of Bacteroides fragilis under anaerobic conditions", FEMS Microbiol Lett, 68, pp.45~50 (1991)
166. Otto BR, "Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake", Infect Immun, 58, pp.3954~3958 (1990)
167. Carpenter C, "Regulation of iron transport systems in Enterobacteriaceae in response to oxygen and iron availability", J Inorg Biochem, 133, pp.110~117 (2014)
168. Hoppe M, "Freeze-dried Lactobacillus plantarum 299v increases iron absorption in young females-Double isotope sequential single-blind studies in menstruating women", PLoS One, 12, pp.e0189141~ (2017)
169. Skrypnik K, "The effect of multispecies probiotic supplementation on iron status in rats", Biol Trace Elem Res, 192, pp.234~243 (2019)
170. Andrews SC, "Making DNA without iron-induction of a manganese-dependent ribonucleotide reductase in response to iron starvation", Mol Microbiol, 80, pp.286~289 (2011)
171. Utley JR, "Pathophysiology of cardiopulmonary bypass : current issues", J Card Surg, 5, pp.177~189 (1990)
172. Hederstedt L, "Two routes for extracellular electron transfer in Enterococcus faecalis", J Bacteriol, 202, pp.e00725~19 (2020)
173. Mey AR, "Iron and fur regulation in Vibrio cholerae and the role of fur in virulence", Infect Immun, 73, pp.8167~8178 (2005)
174. Kramer J, "Bacterial siderophores in community and host interactions", Nat Rev Microbiol, 18, pp.152~163 (2020)
175. Grenier D, "Transferrin as a source of iron for Campylobacter rectus", J Oral Microbiol, 3, pp.3~ (2011)
176. Zhang XH, "Haemolysins in Vibrio species", J Appl Microbiol, 98, pp.1011~1019 (2005)
177. Dekker Nitert M, "Iron supplementation has minor effects on gut microbiota composition in overweight and obese women in early pregnancy", Br J Nutr, 120, pp.283~289 (2018)
178. Alexeev EE, "Effects of iron supplementation on growth, gut microbiota, metabolomics and cognitive development of rat pups", PLoS One, 12, pp.e0179713~ (2017)
179. Perez-Lopez A, "Mucosal immunity to pathogenic intestinal bacteria", Nat Rev Immunol, 16, pp.135~148 (2016)
180. Sassone-Corsi M, "Microcins mediate competition among Enterobacteriaceae in the inflamed gut", Nature, 540, pp.280~283 (2016)
181. Cassat JE, "Iron in infection and immunity", Cell Host Microbe, 13, pp.509~519 (2013)
182. Parmanand BA, "A decrease in iron availability to human gut microbiome reduces the growth of potentially pathogenic gut bacteria; an in vitro colonic fermentation study", J Nutr Biochem, 67, pp.20~27 (2019)
183. Phipps O, "Influence of iron on the gut microbiota in colorectal cancer", Nutrients, 12, pp.2512~ (2020)
184. Fang S, "Oral administration of liquid iron preparation containing excess iron induces intestine and liver injury, impairs intestinal barrier function and alters the gut microbiota in rats", J Trace Elem Med Biol, 47, pp.12~20 (2018)
185. Lönnerdal B, "Excess iron intake as a factor in growth, infections, and development of infants and young children", Am J Clin Nutr, 106, pp.1681~ (2017)
186. Zimmermann MB, "The effects of iron fortification on the gut microbiota in African children : a randomized controlled trial in Cote d'Ivoire", Am J Clin Nutr, 92, pp.1406~1415 (2010)
187. Rivera-Chávez F, "Cholera toxin promotes pathogen acquisition of host-derived nutrients", Nature, 572, pp.244~248 (2019)
188. Li N, "Unique iron coordination in iron-chelating molecule vibriobactin helps Vibrio cholerae evade mammalian siderocalin-mediated immune response", J Biol Chem, 287, pp.8912~8919 (2012)
189. Askoura M, "Investigating the influence of iron on Campylobacter jejuni transcriptome in response to acid stress", Microb Pathog, 138, pp.103777~ (2020)
190. Saha R, "Microbial siderophores : a mini review", J Basic Microbiol, 53, pp.303~317 (2013)
191. Behnsen J, "Siderophores : more than stealing iron", mBio, 7, pp.e01906~16 (2016)
192. Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
193. Zhao H, "Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism", Cell Host Microbe, 12, pp.705~716 (2012)
194. Eller K, "Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis", PLoS One, 8, pp.e67693~ (2013)
195. Bachman MA, "Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin", PLoS Pathog, 5, pp.e1000622~ (2009)
196. Halaas O, "Intracellular Mycobacterium avium intersect transferrin in the Rab11+ recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway", J Infect Dis, 201, pp.783~792 (2010)
197. Holden VI, "Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells", Infect Immun, 82, pp.3826~3836 (2014)
198. Bachman MA, "Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia", mBio, 3, pp.e00224~11 (2012)
199. Jang Y, "Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome", Clin Exp Pharmacol Physiol, 39, pp.194~199 (2012)
200. Taube A, "Inflammation and metabolic dysfunction : links to cardiovascular diseases", Am J Physiol Heart Circ Physiol, 302, pp.H2148~ (2012)
201. Wang Y, "Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans", Clin Chem, 53, pp.34~41 (2007)
202. Choi KM, "Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease", Eur J Endocrinol, 158, pp.203~207 (2008)
203. Law IK, "Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity", Diabetes, 59, pp.872~882 (2010)
204. Guo H, "Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice", Diabetes, 59, pp.1376~1385 (2010)
205. Fülöp P, "Associations of lipocalin 2 with markers of inflammation and oxidant status in obese non-diabetic patients", Atherosclerosis, 252, pp.e69~ (2016)
206. Ito M, "Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge", J Cardiol, 67, pp.184~191 (2016)
207. Wu G, "Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort", Arterioscler Thromb Vasc Biol, 34, pp.2457~2464 (2014)
208. Latouche C, "Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system", Hypertension, 59, pp.966~972 (2012)
209. Hemdahl AL, "Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction", Arterioscler Thromb Vasc Biol, 26, pp.136~142 (2006)
210. )in the development of cardiac hypertrophy and heart failure, "J Am Heart Assoc", 2017, e005971~
211. Falke P, "Leukocyte activation : relation to cardiovascular mortality after cerebrovascular ischemia", Cerebrovasc Dis, 10, pp.97~101 (2000)
212. Sung HK, "Lipocalin-2(NGAL)attenuates autophagy to exacerbate cardiac apoptosis induced by myocardial ischemia", J Cell Physiol, 232, pp.2125~2134 (2017)

관련 논문AI추천